Cargando…
High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
Background and objectives Recent randomized controlled trials (RCTs) have indicated potential therapeutic benefits with high-dose dexamethasone (HDD) or tocilizumab (TCZ) plus standard care in moderate to severe coronavirus disease 2019 (COVID-19) with acute respiratory distress syndrome (ARDS). No...
Autores principales: | Naik, Naveen B, Puri, Goverdhan D, Kajal, Kamal, Mahajan, Varun, Bhalla, Ashish, Kataria, Sandeep, Singla, Karan, Panigrahi, Pritam, Singh, Ajay, Lazar, Michelle, Chander, Anjuman, Ganesh, Venkata, Hazarika, Amarjyoti, Suri, Vikas, Goyal, Manoj K, Pandey, Vijayant Kumar, Kaloria, Narender, Samra, Tanvir, Saini, Kulbhushan, Soni, Shiv L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752381/ https://www.ncbi.nlm.nih.gov/pubmed/35036193 http://dx.doi.org/10.7759/cureus.20353 |
Ejemplares similares
-
Incidence & outcomes of clinically significant bleeding events in critically ill COVID-19 patients receiving Therapeutic dose AntiCoagulanTs: A retrospective cohort study (INTerACT study)
por: Singh, Ajay, et al.
Publicado: (2022) -
Pulmonary Function, Mental and Physical Health in Recovered COVID-19 Patients Requiring Invasive Versus Non-invasive Oxygen Therapy: A Prospective Follow-Up Study Post-ICU Discharge
por: Hazarika, Amarjyoti, et al.
Publicado: (2021) -
Predictors of the Outcomes Following the Tocilizumab Treatment for Severe COVID-19
por: Singla, Karan, et al.
Publicado: (2022) -
Comparison of Midazolam and Propofol Infusion to Suppress Stress Response in Patients With Severe Traumatic Brain Injury: A Prospective, Randomized Controlled Trial
por: Kurni, Mallikarjun, et al.
Publicado: (2023) -
COVID-19-related dynamic coagulation disturbances and anticoagulation strategies using conventional D-dimer and point-of-care Sonoclot tests: a prospective cohort study
por: Premkumar, Madhumita, et al.
Publicado: (2022)